From: Abstracts from the 2018 Respiratory Effectiveness Group Summit
 | Population | Design | Items |
---|---|---|---|
WHO TB Uganda National Survey | 40,000 national representative sample | Cross-sectional | Respiratory symptoms, status of TB, smoking, HIV, Chest XRay |
Uganda Registry Asthma and COPD | (i)Approximately 500 COPD, 500 asthma and 200 Post TB patients (ii) 420 COPD patients in 7 centre | Longitudinal, 6 monthly visits | Spirometry, health status (CCQ), biometrics, exacerbation frequency |
Uganda National Asthma Survey | 3,400 participants over 12year old in 5 districts | Cross-sectional | ISAAC, WHO survey 1 &2, Cardiovascular risk |
Africa Severe Asthma programme | Uganda (826), Kenya, (425), Ethiopia (425). 1676 in total | Cross-sectional | Spirometry, reversibility, questionnaires. Exhaled nitric oxide, blood eosinophils, stool microscopy |
Link survey and FRESH AIR Uganda | 1600 rural participants 1000 Urban (Kampala) | Cross-sectional | Spirometry, symptoms, risk factors biomass and smoking |